New Brunswick, NJ, June 28, 2012 ― The HealthCare Institute of New Jersey (HINJ) has issued the following statement regarding the ruling today by the Supreme Court of the United States pertaining to the Patient Protection and Affordable Care Act of 2010.
* * *
HINJ respects the Supreme Court’s decision and will work with Congress and the Administration in a constructive and bipartisan manner as they assess and address the ruling’s impact on the nation’s current and future healthcare policies.
As we move forward, HINJ’s efforts will be grounded in the core principles that have long guided its advocacy efforts: providing patients with access to high-quality medicines, medical technologies and therapies, and advancing medical innovation while safeguarding New Jersey’s workforce and economy.
HINJ remains committed to working to ensure that medicines and medical technologies are available to patients across the country who rely on New Jersey companies to improve human health and save lives.
Founded in 1997, the HealthCare Institute of New Jersey (HINJ) serves as the voice for the state’s life sciences industry. It seeks to expand public access to the latest and most innovative treatments for diseases and build awareness of the industry’s impact on New Jersey’s quality of life and economic well-being. It helps to advance the development and implementation of sound public health and business policies that support the interests of New Jersey, its people and its life sciences industry. For information, please visit www.hinj.org.